Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SECOND SIGHT MEDICAL PRODUCTS, INC.

(EYES)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
Valuation
Fiscal Period: December 2015 2016 2017 2018 2019 2020
Capitalization1 21183,210967,692,543,2
Entreprise Value (EV)1 21183,210163,183,742,3
P/E ratio -10,5x-2,35x-3,63x-1,67x-2,60x-2,59x
Yield ------
Capitalization / Revenue 23,6x20,9x13,6x9,80x27,4x-
EV / Revenue 23,6x20,9x13,6x9,80x27,4x-
EV / EBITDA -10,7x-2,54x-3,85x-1,98x-3,06x-3,46x
Price to Book --14,0x21,9x12,8x-64,6x
Nbr of stocks (in thousands) 4 4815 2817 1019 54215 57523 118
Reference price (USD) 47,115,815,37,085,941,87
Announcement Date 03/20/201803/19/201903/19/201904/28/202003/16/202103/16/2021
1 USD in Million
Income Statement Evolution (Annual data)
Fiscal Period: December 2015 2016 2017 2018 2019 2020
Net sales1 8,953,997,966,903,38-
EBITDA1 -19,7-32,8-28,2-34,2-30,2-12,5
Operating profit (EBIT)1 -20,0-33,2-28,6-34,6-30,6-12,7
Operating Margin -224%-833%-359%-502%-906%-
Pre-Tax Profit (EBT)1 -20,0-33,2-28,5-35,1-33,6-14,9
Net income1 -20,0-33,2-28,5-35,1-33,6-14,9
Net margin -224%-833%-358%-509%-994%-
EPS2 -4,49-6,71-4,21-4,23-2,28-0,72
Dividend per Share ------
Announcement Date 03/20/201803/19/201903/19/201904/28/202003/16/202103/16/2021
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2019 Q4 2020 Q1 2020 Q2
Net sales1 0,50--
EBITDA1 -8,02-8,80-3,10
Operating profit (EBIT)1 -8,13-8,90-3,12
Operating Margin -1 635%--
Pre-Tax Profit (EBT)1 -7,87-8,89-3,10
Net income1 -7,87-8,89-3,10
Net margin -1 583%--
EPS2 -0,50-0,57-0,15
Dividend per Share ---
Announcement Date 03/19/202006/26/202008/13/2020
1 USD in Million
2 USD
Balance Sheet Analysis
Fiscal Period: December 2015 2016 2017 2018 2019 2020
Net Debt ------
Net Cash position --7,844,478,730,98
Leverage (Debt / EBITDA) --0,28x0,13x0,29x0,08x
Free Cash Flow1 -13,9-13,1-13,6-16,5-13,8-10,8
ROE (Net Profit / Equities) -73,0%-211%-300%-640%-649%-451%
Shareholders' equity1 27,415,79,525,485,183,30
ROA (Net Profit / Asset) -35,1%-92,1%-114%-172%-140%-75,2%
Assets1 57,036,025,020,424,019,8
Book Value Per Share --1,090,320,47-0,03
Cash Flow per Share --1,090,470,720,14
Capex1 0,760,490,270,160,490,33
Capex / Sales 8,51%12,3%3,33%2,36%14,6%-
Announcement Date 03/20/201803/19/201903/19/201904/28/202003/16/202103/16/2021
1 USD in Million
Key data
Capitalization (USD) 115 074 793
Number of employees 11
Free-Float 74,8%
Free-Float capitalization (USD) 86 034 357
Avg. Exchange 20 sessions () 2 143 645
Avg. Exchange 20 sessions (USD) 0,00
Average Daily Capital Traded 1,86%
EPS & Dividend